A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease - PubMed (original) (raw)
Case Reports
. 2007 Aug;21(8):1839-41.
doi: 10.1038/sj.leu.2404728. Epub 2007 May 17.
- PMID: 17508004
- DOI: 10.1038/sj.leu.2404728
Case Reports
A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease
C E Curtis et al. Leukemia. 2007 Aug.
No abstract available
Similar articles
- Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
Apperley JF, Gardembas M, Melo JV, Russell-Jones R, Bain BJ, Baxter EJ, Chase A, Chessells JM, Colombat M, Dearden CE, Dimitrijevic S, Mahon FX, Marin D, Nikolova Z, Olavarria E, Silberman S, Schultheis B, Cross NC, Goldman JM. Apperley JF, et al. N Engl J Med. 2002 Aug 15;347(7):481-7. doi: 10.1056/NEJMoa020150. N Engl J Med. 2002. PMID: 12181402 - KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.
Medves S, Duhoux FP, Ferrant A, Toffalini F, Ameye G, Libouton JM, Poirel HA, Demoulin JB. Medves S, et al. Leukemia. 2010 May;24(5):1052-5. doi: 10.1038/leu.2010.13. Epub 2010 Feb 18. Leukemia. 2010. PMID: 20164854 No abstract available. - KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32).
Levine RL, Wadleigh M, Sternberg DW, Wlodarska I, Galinsky I, Stone RM, DeAngelo DJ, Gilliland DG, Cools J. Levine RL, et al. Leukemia. 2005 Jan;19(1):27-30. doi: 10.1038/sj.leu.2403548. Leukemia. 2005. PMID: 15496975 - Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders.
Cortes J, Kantarjian H. Cortes J, et al. Cancer. 2004 May 15;100(10):2064-78. doi: 10.1002/cncr.20211. Cancer. 2004. PMID: 15139047 Review. - Translocation t(12;13)(p13;q14) in a patient with imatinib-sensitive MDS/MPD associated with resistance to treatment: review of the literature.
Diamantopoulos PT, Athanasiadou A, Papakostas E, Gratsias N, Georgiou G, Mantzourani M, Andreopoulos G, Panagiotidis P, Aessopos A, Meletis J, Viniou N. Diamantopoulos PT, et al. Anticancer Drugs. 2011 Oct;22(9):944-7. doi: 10.1097/CAD.0b013e3283486ca4. Anticancer Drugs. 2011. PMID: 21712707 Review.
Cited by
- Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.
Nguyen L, Saha A, Kuykendall A, Zhang L. Nguyen L, et al. Cancers (Basel). 2024 Mar 31;16(7):1383. doi: 10.3390/cancers16071383. Cancers (Basel). 2024. PMID: 38611061 Free PMC article. Review. - Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain.
van Outersterp I, Tasian SK, Reichert CEJ, Boeree A, de Groot-Kruseman HA, Escherich G, Boer JM, den Boer ML. van Outersterp I, et al. Blood. 2024 May 23;143(21):2178-2189. doi: 10.1182/blood.2023023120. Blood. 2024. PMID: 38394665 Free PMC article. - Myeloproliferative Neoplasm Driven by ETV6-ABL1 in an Adolescent with Recent History of Burkitt Leukemia.
Renzi S, Algawahmed F, Davidson S, Langenberg KPS, Fuligni F, Ali S, Anderson N, Brunga L, Bartram J, Abdelhaleem M, Naqvi A, Beimnet K, Schuh A, Tierens A, Malkin D, Shlien A, Shago M, Villani A. Renzi S, et al. Curr Oncol. 2023 Jun 21;30(7):5946-5952. doi: 10.3390/curroncol30070444. Curr Oncol. 2023. PMID: 37503586 Free PMC article. - Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.
Stella S, Massimino M, Manzella L, Pennisi MS, Tirrò E, Romano C, Vitale SR, Puma A, Tomarchio C, Gregorio SD, Palumbo GA, Vigneri P. Stella S, et al. Int J Mol Sci. 2021 Jan 6;22(2):486. doi: 10.3390/ijms22020486. Int J Mol Sci. 2021. PMID: 33418988 Free PMC article. Review. - Multiple _MYO18A_-PDGFRB fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11).
Sheng G, Zeng Z, Pan J, Kou L, Wang Q, Yao H, Wen L, Ma L, Wu D, Qiu H, Chen S. Sheng G, et al. Mol Cytogenet. 2017 Feb 27;10:4. doi: 10.1186/s13039-017-0306-8. eCollection 2017. Mol Cytogenet. 2017. PMID: 28261327 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous